JSB Market Research: Myasthenia Gravis - Pipeline Review, H2 2014
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. See Full Report @ http://bit.ly/1BXnzhj
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
See Full Report @ http://bit.ly/1BXnzhj
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Product Description 56<br />
Mechanism of Action 56<br />
R&D Progress 56<br />
Regenemab - Drug Profile 57<br />
Product Description 57<br />
Mechanism of Action 57<br />
R&D Progress 57<br />
tacrolimus - Drug Profile 58<br />
Product Description 58<br />
Mechanism of Action 58<br />
R&D Progress 58<br />
tirasemtiv - Drug Profile 59<br />
Product Description 59<br />
Mechanism of Action 59<br />
R&D Progress 59<br />
Vaccine for <strong>Myasthenia</strong> <strong>Gravis</strong> - Drug Profile 62<br />
Product Description 62<br />
Mechanism of Action 62<br />
R&D Progress 62<br />
Vaccine for <strong>Myasthenia</strong> <strong>Gravis</strong> - Drug Profile 63<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language